Unverified50% confidencePredictionExact time
High-quality AI-ready biological data is expected to significantly shorten drug discovery timelines.
1
Sources
50%
Confidence
Medium-term (~90 days)
Relevance
10/8/2026
First Seen
Valid until: 1/6/2027
Sources
Related Entities
Related Claims
UnverifiedClinical pharmacy + AI (prescription review, adverse reaction monitoring, real-world research) is the pharmaceutical AI track with the lowest entry barrier.72% similarUnverifiedAutomated blood smear analysis combined with laboratory testing may help reduce the risk of such misdiagnoses in the future.65% similarUnverified医学AI临床验证的性能基准须针对目标人群建立，不能直接沿用公开数据集的评测结果，需通过多中心前瞻性研究证明安全性和有效性64% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/989895API
curl https://kongchang.com/api/v1/knowledge/claims/989895MCP
get_claim(id=989895)